New ADHD drug is safe for children as 'it's not addictive'
Experts say it could be a better option for children than other medicines for them that contain stimulants, which increase heart rate and can be addictive.
Source: dailymail.co.uk
Tris Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tris Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tris Pharma Today - Breaking & Trending Today
One in Nine Kids Have ADHD; Placebo Response in Trials; Befriending Former Patients
News and commentary from the psychiatry world
Source: medpagetoday.com
FDA Approves Clonidine Hydrochloride For Treatment of ADHD in Pediatric Patients
The treatment is the first liquid non-stimulant for attention deficit hyperactivity disorder to be approved in the United States.
Source: pharmacytimes.com
Onyda XR: The First and Only Liquid Nonstimulant ADHD Medication
Onyda XR is the first and only liquid nonstimulant ADHD medication approved in the US and the only approved nonstimulant ADHD medication with nighttime dosing.
Source: psychiatrictimes.com
FDA approves Tris Pharma's daily nighttime ADHD therapy
Tris has won FDA approval for Onyda XR for ADHD. The extended-release oral suspension becomes the first liquid non-stimulant med for the indication.
Source: fiercepharma.com